- •
Precise diagnosis of hepatocellular carcinoma (HCC) requires clinical, radiological, and histologic correlation.
- •
Ancillary tests should be used cautiously while establishing a diagnosis of HCC.
- •
Certain subtypes of HCC have molecular correlates that have an impact on prognosis and treatment.
Hepatocellular Carcinoma: Role of Pathology in the Era of Precision Medicine
Section snippets
Key points
Diagnosis of hepatocellular carcinoma
Knowledge of clinical and radiologic findings is paramount for the pathologist while making the diagnosis of HCC. Clinical information, especially age, is very helpful and can point to certain diagnoses. Presence of risk factors, such as metabolic disorders, nonalcoholic steatohepatitis (NASH), and viral hepatitis, increases the likelihood of detecting abnormality in the pathology specimen. Similarly, the importance of radiologic impression cannot be overemphasized. In many instances when the
Major hepatocellular carcinoma subtypes
Many architectural growth patterns and histologic subtypes of HCC have been recognized. It is important to identify the morphologic spectrum of HCC not only to enable accurate diagnosis but also for prognostication. Histologic subtypes should not be confused with architectural growth patterns. Although there are 4 major architectural growth patterns, there can be many histologic subtypes (Table 2). The 4 major architectural growth patterns include trabecular, solid/compact,
Morpho-molecular classification of hepatocellular carcinoma
The molecular classification of HCC has evolved dramatically over the past decade. The Cancer Genome Atlas Research Network results showed that TERT promoter, TP53 and CTNNB1 were seen in more than 70% of HCCs.97 This work was further advanced by the French classification group, which not only provided molecular classification groups but also introduced several morphologic categories based on histologic and molecular correlation.62 The HCCs were classified into 6 groups based on proliferative
Summary
Comprehensive molecular profiling of HCC has ushered a new era in the pathology of hepatocellular neoplasms. morpho-molecular correlation studies have enabled identification of histologic features associated with specific molecular alterations. The role of pathology has shifted from mere diagnosis to prediction of prognosis and response to targeted therapy. In addition to guiding the surgeon’s hand, pathology is now also guiding oncologists in treating patients in this era of precision
Disclosure
The authors have nothing to disclose.
References (100)
- et al.
Hepatic precancerous lesions and small hepatocellular carcinoma
Gastroenterol Clin North Am
(2007) - et al.
Diagnostic approach to hepatic mass lesions and role of immunohistochemistry
Surg Pathol Clin
(2013) - et al.
Liver precancerous lesions and hepatocellular carcinoma: the histology report
Dig Liver Dis
(2011) - et al.
Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens
Hum Pathol
(2017) - et al.
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma
J Hepatol
(2009) - et al.
Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma
Hepatology
(2003) - et al.
Arginase-1 is frequently positive in hepatoid adenocarcinomas
Hum Pathol
(2016) - et al.
A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative
Hum Pathol
(2017) - et al.
Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma
Mod Pathol
(2013) - et al.
Hep Par 1 antibody stain for of hepatocellular carcinoma: the differential diagnosis 676 tumors tested using tissue microarrays and conventional tissue sections
Mod Pathol
(2003)